148 related articles for article (PubMed ID: 19493272)
1. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth.
Taniguchi K; Ishizaki T; Ayada T; Sugiyama Y; Wakabayashi Y; Sekiya T; Nakagawa R; Yoshimura A
Cancer Sci; 2009 Sep; 100(9):1648-54. PubMed ID: 19493272
[TBL] [Abstract][Full Text] [Related]
2. Sprouty4 negatively regulates protein kinase C activation by inhibiting phosphatidylinositol 4,5-biphosphate hydrolysis.
Ayada T; Taniguchi K; Okamoto F; Kato R; Komune S; Takaesu G; Yoshimura A
Oncogene; 2009 Feb; 28(8):1076-88. PubMed ID: 19137008
[TBL] [Abstract][Full Text] [Related]
3. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
4. Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation.
Sasaki A; Taketomi T; Wakioka T; Kato R; Yoshimura A
J Biol Chem; 2001 Sep; 276(39):36804-8. PubMed ID: 11495895
[TBL] [Abstract][Full Text] [Related]
5. A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras.
Desroches-Castan A; Quélard D; Demeunynck M; Constant JF; Dong C; Keramidas M; Coll JL; Barette C; Lafanechère L; Feige JJ
Oncotarget; 2015 Mar; 6(7):5382-411. PubMed ID: 25742784
[TBL] [Abstract][Full Text] [Related]
6. Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling.
Taniguchi K; Ayada T; Ichiyama K; Kohno R; Yonemitsu Y; Minami Y; Kikuchi A; Maehara Y; Yoshimura A
Biochem Biophys Res Commun; 2007 Jan; 352(4):896-902. PubMed ID: 17156747
[TBL] [Abstract][Full Text] [Related]
7. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.
Du W; Takuwa N; Yoshioka K; Okamoto Y; Gonda K; Sugihara K; Fukamizu A; Asano M; Takuwa Y
Cancer Res; 2010 Jan; 70(2):772-81. PubMed ID: 20068174
[TBL] [Abstract][Full Text] [Related]
8. Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.
Reynolds LE; Watson AR; Baker M; Jones TA; D'Amico G; Robinson SD; Joffre C; Garrido-Urbani S; Rodriguez-Manzaneque JC; Martino-Echarri E; Aurrand-Lions M; Sheer D; Dagna-Bricarelli F; Nizetic D; McCabe CJ; Turnell AS; Kermorgant S; Imhof BA; Adams R; Fisher EM; Tybulewicz VL; Hart IR; Hodivala-Dilke KM
Nature; 2010 Jun; 465(7299):813-7. PubMed ID: 20535211
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of 2-oxoglutarate through inhibition of angiogenesis in a murine tumor model.
Matsumoto K; Obara N; Ema M; Horie M; Naka A; Takahashi S; Imagawa S
Cancer Sci; 2009 Sep; 100(9):1639-47. PubMed ID: 19575748
[TBL] [Abstract][Full Text] [Related]
10. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
[TBL] [Abstract][Full Text] [Related]
11. R-Ras protein inhibits autophosphorylation of vascular endothelial growth factor receptor 2 in endothelial cells and suppresses receptor activation in tumor vasculature.
Sawada J; Li F; Komatsu M
J Biol Chem; 2015 Mar; 290(13):8133-45. PubMed ID: 25645912
[TBL] [Abstract][Full Text] [Related]
12. The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade.
Nisancioglu MH; Betsholtz C; Genové G
Cancer Res; 2010 Jun; 70(12):5109-15. PubMed ID: 20501841
[TBL] [Abstract][Full Text] [Related]
13. Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis.
Hayashi M; Fearns C; Eliceiri B; Yang Y; Lee JD
Cancer Res; 2005 Sep; 65(17):7699-706. PubMed ID: 16140937
[TBL] [Abstract][Full Text] [Related]
14. Glyceollins, a novel class of soy phytoalexins, inhibit angiogenesis by blocking the VEGF and bFGF signaling pathways.
Lee SH; Lee J; Jung MH; Lee YM
Mol Nutr Food Res; 2013 Feb; 57(2):225-34. PubMed ID: 23229497
[TBL] [Abstract][Full Text] [Related]
15. Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis.
Taniguchi K; Sasaki K; Watari K; Yasukawa H; Imaizumi T; Ayada T; Okamoto F; Ishizaki T; Kato R; Kohno R; Kimura H; Sato Y; Ono M; Yonemitsu Y; Yoshimura A
PLoS One; 2009; 4(5):e5467. PubMed ID: 19424491
[TBL] [Abstract][Full Text] [Related]
16. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
[TBL] [Abstract][Full Text] [Related]
17. Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice.
Yi M; Schnitzer JE
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17886-91. PubMed ID: 19805119
[TBL] [Abstract][Full Text] [Related]
18. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hindlimbs of mice.
Oyama O; Sugimoto N; Qi X; Takuwa N; Mizugishi K; Koizumi J; Takuwa Y
Cardiovasc Res; 2008 May; 78(2):301-7. PubMed ID: 18187460
[TBL] [Abstract][Full Text] [Related]
19. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
[TBL] [Abstract][Full Text] [Related]
20. Breaking the 'harmony' of TNF-α signaling for cancer treatment.
Sasi SP; Yan X; Enderling H; Park D; Gilbert HY; Curry C; Coleman C; Hlatky L; Qin G; Kishore R; Goukassian DA
Oncogene; 2012 Sep; 31(37):4117-27. PubMed ID: 22158049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
